These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23909604)

  • 1. Relationships between serotoninergic system and skin fibrotic.
    Huang J; Gong Q; Huang C; Li G
    Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):9-16. PubMed ID: 23909604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biologics and other novel therapies for the treatment of systemic sclerosis.
    Bruni C; Praino E; Allanore Y; Distler O; Gabrielli A; Iannone F; Matucci-Cerinic M
    Expert Rev Clin Immunol; 2017 May; 13(5):469-482. PubMed ID: 27899043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.
    Yan Y; Zhou P; Rotella DP; Feenstra R; Kruse CG; Reinders JH; van der Neut M; Lai M; Zhang J; Kowal DM; Carrick T; Marquis KL; Pausch MH; Robichaud AJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2983-6. PubMed ID: 20347298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin reuptake blocker citalopram destabilizes fictive locomotor activity in salamander axial circuits through 5-HT
    Flaive A; Cabelguen JM; Ryczko D
    J Neurophysiol; 2020 Jun; 123(6):2326-2342. PubMed ID: 32401145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future treatments in systemic sclerosis.
    Asano Y
    J Dermatol; 2010 Jan; 37(1):54-70. PubMed ID: 20175840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis.
    Liu Q; Lu J; Lin J; Tang Y; Pu W; Shi X; Jiang S; Liu J; Ma Y; Li Y; Xu J; Jin L; Wang J; Wu W
    Biomed Pharmacother; 2019 Feb; 110():546-553. PubMed ID: 30530290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and systemic sclerosis. An emerging player in pathogenesis.
    Sagonas I; Daoussis D
    Joint Bone Spine; 2022 May; 89(3):105309. PubMed ID: 34800695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
    Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging targeted therapies in scleroderma lung and skin fibrosis.
    Maurer B; Distler O
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):843-58. PubMed ID: 22265265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress.
    Wu HL; Pang SL; Liu QZ; Wang Q; Cai MX; Shang J
    PLoS One; 2014; 9(2):e89663. PubMed ID: 24586946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
    Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
    Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
    Usategui A; del Rey MJ; Pablos JL
    Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.
    Hofmann C; Penner U; Dorow R; Pertz HH; Jähnichen S; Horowski R; Latté KP; Palla D; Schurad B
    Clin Neuropharmacol; 2006; 29(2):80-6. PubMed ID: 16614540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacological basis of the serotonin system: Application to antidepressant response].
    David DJ; Gardier AM
    Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.